54 213 54 213 (Lithium 150 mg)
Pill with imprint 54 213 54 213 is White, Capsule-shape and has been identified as Lithium carbonate 150 mg. It is supplied by Roxane Laboratories, Inc..
Lithium is used in the treatment of bipolar disorder; borderline personality disorder; schizoaffective disorder; mania; cluster headaches (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 150 mg is not a controlled substance under the Controlled Substance Act (CSA).
Images for 54 213 54 213
- 54 213 54 213
- 150 mg
- 4.00 mm
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Roxane Laboratories, Inc.
- Inactive Ingredients:
- FD&C Red No. 40
sodium lauryl sulfate
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
|NDC Code||Labeler / Repackager|
|00054-2526||Roxane Laboratories, Inc.|
More about lithium
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 276 Reviews – Add your own review/rating
- Drug class: miscellaneous antipsychotic agents
- Lithium Capsules and Tablets
- Lithium Controlled-Release and Extended-Release Tablets
- Lithium Syrup and Oral Solution
- Lithium (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.